Drug Trial Radar · NCT07271667
A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell Malignancies
Last checked: Nov 19, 2026Latest source record: Jun 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
108
Planned (sponsor's estimate)
Start
Apr 23, 2026
Primary completion
Nov 2027
Study completion Nov 2027
Sponsor
- Lead sponsor
- Curis, Inc.Industry
- Sponsor type
- Industry
- First posted
- Dec 9, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of the study for Cohort 1 and Cohort 2 is to assess the anticancer activity of emavusertib in combination with zanubrutinib in participants with CLL.
Conditions
- Chronic Lymphocytic Leukemia
- B-cell Malignancies
Interventions
EmavusertibDrug
Oral tablets
ZanubrutinibDrug
Oral capsules
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cohort 1: Undetectable Measurable Residual Disease (uMRD) RateTime frame: Up to approximately 23 months
- Cohort 2: Overall Response Rate (ORR)Time frame: Up to approximately 23 months
Locations
11 sites in 3 countries. Site status is shown where the registry gives one.
Mt Sinai Comprehensive Cancer Center
Miami Beach, Florida · Recruiting
Mayo Clinic
Rochester, Minnesota · Recruiting
Summit Medical Group
Florham Park, New Jersey · Recruiting
Ohio State University Comprehensive Cancer Center
Columbus, Ohio · Recruiting
UPMC Hillman Cancer Center
Pittsburgh, Pennsylvania · Recruiting
Texas Oncology - Sammons Cancer Center
Dallas, Texas · Recruiting
IRCCS Ospedale San Raffaele
Milan, Italy · Recruiting
Azienda Ospedaliero Universitaria Maggiore Della Carità
Novara, Italy · Recruiting
Azienda Ospedale Università Padova
Padova, Italy · Recruiting
MD Anderson Cancer Center Madrid
Madrid, Spain · Recruiting
Hospital Universitario Fundación Jiménez Díaz - START MADRID
Madrid, Spain · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.